| 2025年年报 | 2025年三季报 | 2025年中报 | 2025年一季报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|---|
| 营业收入(元) | ||||||
| 技术使用费(元) | - | - | - | - | - | 1,089,369.01 |
| 铝镁匹林片(II)(元) | 536,557,400.39 | 405,316,607.08 | 231,698,207.16 | 85,738,289.81 | - | 194,011,571.99 |
| 医药研发(元) | - | - | - | - | - | 84,905.66 |
| 银杏叶胶囊(元) | 17,304,232.06 | 13,491,579.01 | 9,686,352.61 | 4,844,077.35 | 18,612,421.40 | 9,161,065.60 |
| 铝镁匹林片(Ⅱ)(元) | - | - | - | - | 406,018,322.64 | - |
| 通心舒胶囊(元) | 20,416,528.61 | 15,003,562.27 | 8,946,629.90 | - | - | - |
| 其他产品(元) | 3,001,194.86 | 2,014,626.20 | 1,061,314.93 | 3,440,286.70 | 16,663,774.85 | 7,174,535.50 |
| 营业成本(元) | ||||||
| 技术使用费(元) | - | - | - | - | - | 1,425,038.76 |
| 铝镁匹林片(II)(元) | 25,197,141.22 | 19,218,153.38 | 11,873,181.00 | 5,407,841.38 | - | 8,574,198.70 |
| 医药研发(元) | - | - | - | - | - | 68,409.34 |
| 银杏叶胶囊(元) | 5,714,339.27 | 4,384,195.92 | 3,106,021.44 | 1,508,340.41 | 5,267,177.97 | 2,385,460.76 |
| 铝镁匹林片(Ⅱ)(元) | - | - | - | - | 19,496,512.98 | - |
| 通心舒胶囊(元) | 3,724,435.10 | 2,555,946.13 | 1,636,993.64 | - | - | - |
| 其他产品(元) | 2,132,263.61 | 1,909,780.24 | 769,934.27 | 767,234.07 | 3,140,852.90 | 1,240,489.47 |
| 毛利(元) | ||||||
| 技术使用费(元) | - | - | - | - | - | -335,669.75 |
| 铝镁匹林片(II)(元) | 511,360,259.17 | 386,098,453.70 | 219,825,026.16 | 80,330,448.43 | - | 185,437,373.29 |
| 医药研发(元) | - | - | - | - | - | 16,496.32 |
| 银杏叶胶囊(元) | 11,589,892.79 | 9,107,383.09 | 6,580,331.17 | 3,335,736.94 | 13,345,243.43 | 6,775,604.84 |
| 铝镁匹林片(Ⅱ)(元) | - | - | - | - | 386,521,809.66 | - |
| 通心舒胶囊(元) | 16,692,093.51 | 12,447,616.14 | 7,309,636.26 | - | - | - |
| 其他产品(元) | 868,931.25 | 104,845.96 | 291,380.66 | 2,673,052.63 | 13,522,921.95 | 5,934,046.03 |
| 毛利率(%) | ||||||
| 技术使用费(%) | - | - | - | - | - | -30.81 |
| 铝镁匹林片(II)(%) | 95.30 | 95.26 | 94.88 | 93.69 | - | 95.58 |
| 医药研发(%) | - | - | - | - | - | 19.43 |
| 银杏叶胶囊(%) | 66.98 | 67.50 | 67.93 | 68.86 | 71.70 | 73.96 |
| 铝镁匹林片(Ⅱ)(%) | - | - | - | - | 95.20 | - |
| 通心舒胶囊(%) | 81.76 | 82.96 | 81.70 | - | - | - |
| 其他产品(%) | 28.95 | 5.20 | 27.45 | 77.70 | 81.15 | 82.71 |
| 收入构成(%) | ||||||
| 技术使用费(%) | - | - | - | - | - | 0.52 |
| 铝镁匹林片(II)(%) | 92.95 | 93.00 | 92.17 | 91.19 | - | 91.72 |
| 医药研发(%) | - | - | - | - | - | 0.04 |
| 银杏叶胶囊(%) | 3.00 | 3.10 | 3.85 | 5.15 | 4.22 | 4.33 |
| 铝镁匹林片(Ⅱ)(%) | - | - | - | - | 92.01 | - |
| 通心舒胶囊(%) | 3.54 | 3.44 | 3.56 | - | - | - |
| 其他产品(%) | 0.52 | 0.46 | 0.42 | 3.66 | 3.78 | 3.39 |
| 毛利构成(%) | ||||||
| 技术使用费(%) | - | - | - | - | - | -0.17 |
| 铝镁匹林片(II)(%) | 94.61 | 94.69 | 93.94 | 93.04 | - | 93.74 |
| 医药研发(%) | - | - | - | - | - | 0.01 |
| 银杏叶胶囊(%) | 2.14 | 2.23 | 2.81 | 3.86 | 3.23 | 3.43 |
| 铝镁匹林片(Ⅱ)(%) | - | - | - | - | 93.50 | - |
| 通心舒胶囊(%) | 3.09 | 3.05 | 3.12 | - | - | - |
| 其他产品(%) | 0.16 | 0.03 | 0.12 | 3.10 | 3.27 | 3.00 |